Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

Childhood Cancer 2016

A novel biomarker for paediatic tumours

Dr Kathleen Birley - UCL Institute of Child Health, London, UK

A novel biomarker for paediatic tumours ( Dr Kathleen Birley - UCL Institute of Child Health, London, UK )

Paediatric ALL with brain metastases

Dr Christina Halsey - University of Glasgow, Glasgow, UK

Paediatric ALL with brain metastases ( Dr Christina Halsey - University of Glasgow, Glasgow, UK )

miRNA screening for germ cell tumours

Dr Matthew Murray - University of Cambridge, Cambridge, UK

miRNA screening for germ cell tumours ( Dr Matthew Murray - University of Cambridge, Cambridge, UK )

ALK mutations in paediatric tumours

Dr Suzanne Turner - Cambridge University, Cambridge, UK

ALK mutations in paediatric tumours ( Dr Suzanne Turner - Cambridge University, Cambridge, UK )

Can we reduce exposure to risk factors associated with childhood leukaemia and other cancers?

Dr Mark Miller - UCSF, San Francisco, USA

Can we reduce exposure to risk factors associated with childhood leukaemia and other cancers? ( Dr Mark Miller - UCSF, San Francisco, USA )

Risk factors for childhood cancer: what are the challenges in research?

Dr Kurt Straif - IARC, Lyon, France

Risk factors for childhood cancer: what are the challenges in research? ( Dr Kurt Straif - IARC, Lyon, France )

Genetic polymorphisms associated with childhood AML

Dr Gisele Brisson - Instituto Nacional de Cancer, Rio de Janeiro, Brazil

Genetic polymorphisms associated with childhood AML ( Dr Gisele Brisson - Instituto Nacional de Cancer, Rio de Janeiro, Brazil )

Making sense of genetic associations with childhood leukaemia risk

Prof Mehmet Dorak - Liverpool Hope University, Liverpool, UK

Making sense of genetic associations with childhood leukaemia risk ( Prof Mehmet Dorak - Liverpool Hope University, Liverpool, UK )

Childhood Cancer 2016: The potential of immunotherapy

Dr John Anderson - University College London, London, UK

Childhood Cancer 2016: The potential of immunotherapy ( Dr John Anderson - University College London, London, UK )

Childhood Cancer 2016: Conference review

Prof Persis Amrolia - Great Ormond Street Hopsital for Children, London, UK

Childhood Cancer 2016: Conference review ( Prof Persis Amrolia - Great Ormond Street Hopsital for Children, London, UK )

Childhood leukaemia and natural background radiation

Dr Gerald Kendall - University of Oxford, Oxford, UK

Childhood leukaemia and natural background radiation ( Dr Gerald Kendall - University of Oxford, Oxford, UK )

Antibody-based and bispecific T-cell dependent therapies

Dr Nai-Kong Cheung - Memorial Sloan Kettering Cancer Center, New York, USA

Antibody-based and bispecific T-cell dependent therapies ( Dr Nai-Kong Cheung - Memorial Sloan Kettering Cancer Center, New York, USA )

NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls

Dr Daniel Lee - University of Virginia, Charlottesville, USA

NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls ( Dr Daniel Lee - University of Virginia, Charlottesville, USA )

Diet, transplacental carcinogenesis and risk to children: results from the NewGeneris project

Prof Soterios Kyrtopoulos - National Hellenic Research Foundation, Athens, Greece

Diet, transplacental carcinogenesis and risk to children: results from the NewGeneris project ( Prof Soterios Kyrtopoulos - National Hellenic Research Foundation, Athens, Greece )

Environmental exposure and childhood leukaemia

Prof Denis Henshaw - University of Bristol, Bristol, UK

Environmental exposure and childhood leukaemia ( Prof Denis Henshaw - University of Bristol, Bristol, UK )

The CAR T cell revolution in cancer therapy

Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA

The CAR T cell revolution in cancer therapy ( Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA )

Development of a novel CD19 CAR with improved functionality

Anne Kramer - PhD student, University College London, London, UK

Development of a novel CD19 CAR with improved functionality ( Anne Kramer - PhD student, University College London, London, UK )

Immune strategies for treating neuroblastoma

Dr Karin Straathof - UCL Institute of Child Health, London, UK

Immune strategies for treating neuroblastoma ( Dr Karin Straathof - UCL Institute of Child Health, London, UK )

Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL

Dr Sara Ghorashian - University College London, London, UK

Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL ( Dr Sara Ghorashian - University College London, London, UK )

DNA methylation as a mediator of in utero exposures on the risk of childhood ALL

Jessica Timms - PhD student, Newcastle University, Newcastle, UK

DNA methylation as a mediator of in utero exposures on the risk of childhood ALL ( Jessica Timms - PhD student, Newcastle University, Newcastle, UK )

More from ecancer